Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03684980
Title LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

B-cell lymphoma

central nervous system lymphoma

Therapies

Glucarpidase + Leucovorin + Methotrexate + Rituximab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.